Robert E. Claypoole - Jan 11, 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
President and CEO, Director
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Jan 11, 2024
Transactions value $
$0
Form type
4
Date filed
1/12/2024, 04:52 PM
Previous filing
Jan 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +375K $0.00 375K Jan 11, 2024 Class A Common Stock 375K Direct F1, F2
transaction BVS Stock Option (Right to Buy) Award $0 +850K $0.00 850K Jan 11, 2024 Class A Common Stock 850K $4.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock units and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of January 10, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.